Hydrofarm Group (HYFM) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
30 Apr, 2026Executive summary
The 2026 annual meeting will be held virtually on June 23, 2026, with voting available online, by phone, or by mail.
Stockholders will vote on electing one Class III director, an advisory say-on-pay vote, and ratification of the independent auditor.
The board recommends voting in favor of all proposals.
Proxy materials are distributed electronically to conserve resources and reduce costs.
Voting matters and shareholder proposals
Proposals include electing Richard Christopher Yetter as Class III director for a three-year term, approving executive compensation, and ratifying CBIZ CPAs P.C. as the independent auditor.
Voting is open to stockholders of record as of April 24, 2026.
Advisory votes are non-binding but will be considered in future compensation decisions.
Shareholder proposals for the 2027 meeting must be received by December 31, 2026.
Board of directors and corporate governance
The board consists of five members divided into three classes, with staggered three-year terms.
All directors except the CEO are independent under Nasdaq rules.
Committees include Audit, Compensation, and Nominating, each with defined charters and independent members.
The board chair and CEO roles are currently combined.
Directors are encouraged, but not required, to attend annual meetings.
Latest events from Hydrofarm Group
- Q2 2026 saw a 40.9% sales drop, improved margins, and ongoing liquidity and default risks.HYFM
Q2 2026 - Director election, executive pay, and auditor ratification all passed with no shareholder questions.HYFM
AGM 2026 - Annual meeting on June 23, 2026; all stockholders urged to vote online or by phone.HYFM
Proxy filing - Sales fell 29.6% with deepening losses and persistent liquidity risks despite cost cuts.HYFM
Q1 2026 - Virtual annual meeting to vote on director, executive pay, and auditor ratification.HYFM
Proxy filing - Net sales fell 32.7% and a major impairment drove a $242M net loss amid ongoing restructuring.HYFM
Q4 2025 - Gross margin improved to 19.4% as net loss narrowed and 2024 outlook was reaffirmed.HYFM
Q3 2024 - Sales dropped 13% and net loss widened, but positive adjusted EBITDA and outlook reaffirmed.HYFM
Q2 2024 - 2025 outlook expects lower sales but improved margins and free cash flow amid industry headwinds.HYFM
Q4 2024